Yanzheng Zhang
Dallas, TXNPI 1831399880
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $1,406,653 of the $1,406,676 with a category attached, or 100.0%. 3 manufacturers reported payments, led by CSL Plasma Inc. at 58.2% of the total.
$1,406,676in general payments, 2019–2025
Across 845 payments — averaging $1664.71 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- CSL Plasma Inc.$819K
- CSL Behring$588K
- Terumo BCT, Inc.$24
What the payments were for
- Consulting fees$1,406,653100%
- Food & beverage$240%
General payments by program year
19
20
21
22
23
24
25
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| CSL Plasma Inc. | 464 | $819,083 |
| CSL Behring | 380 | $587,570 |
| Terumo BCT, Inc. | 1 | $24 |
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.